Medicare Enrolled

Dr. Hiren Patel, MD

Cardiovascular Disease · Port Charlotte, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
3115 HARBOR BLVD, Port Charlotte, FL 33952
9412583635
In practice since 2006 (19 years)
NPI: 1114951225 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Hiren Patel is a cardiovascular disease in Port Charlotte, FL, with 19 years in practice. Based on federal Medicare data, Dr. Patel performed 21,142 Medicare services across 5,914 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $13,658 from 43 pharmaceutical and/or device companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 1% volume in FL$ $13,658 industry payments

Medicare Practice Summary

Medicare Utilization ↗
21,142
Medicare services
Top 1% in FL for cardiovascular disease
5,914
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,113 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)12,762$0$4
Technetium tc-99m sestamibi, diagnostic, per study dose1,177$90$222
Office visit, established patient (30-39 min)1,017$93$170
Electrocardiogram (EKG), 12-lead709$11$30
Office visit, established patient, complex (40-54 min)659$134$280
Echocardiogram, transthoracic621$145$350
Regadenoson injection (Lexiscan) for heart stress test620$33$120
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician593$48$150
Nuclear medicine studies of heart muscle at rest and with stress and spect590$336$740
Nuclear medicine study of heart pumping function with measurement of internal blood volume ejected with every beat over a single cycle554$126$276
Ultrasound of both sides of head and neck blood flow331$131$300
Evaluation of cardiac rhythm monitor system, remote up to 30 days198$20$68
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec198$28$82
Hospital follow-up visit, high complexity139$96$160
Ultrasound of leg arteries or artery grafts128$182$300
Ultrasound of aorta, vena cava, groin vessels or bypass grafts112$74$180
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional97$17$32
Hospital follow-up visit, moderate complexity80$64$108
New patient office visit, complex (60-74 min)78$168$310
Programming of dual lead pacemaker system66$57$86
Initial hospital admission, high complexity53$140$310
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional47$50$200
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes43$10$65
Remote pacemaker/defibrillator monitoring, 90 days37$17$39
Insertion of heart rhythm monitor under skin33$3,341$6,000
Insertion of tube into first order main and accessory arteries of both kidneys for imaging with review by radiologist33$148$600
Programming of multiple lead implantable defibrillator system31$76$131
Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist28$247$640
Ultrasound study of arm or leg veins with compression and maneuvers24$129$276
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days22$28$100
Programming of dual lead implantable defibrillator system19$70$120
Coronary stent placement18$463$1,000
Remote pacemaker monitoring, 90 days14$24$50
Initial hospital admission, moderate complexity11$106$210
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.4% high complexity
74.0% medium
21.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,658
Total received (2018-2024)
Avg $1,951/year across 7 years
Top 19% in FL for cardiovascular disease
43
Companies
301
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,426 (54.4%)
Scientific / Research
Research funding and grants
$6,232 (45.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,947
2023
$4,856
2022
$1,300
2021
$898
2020
$488
2019
$1,503
2018
$667

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$6,266
Penumbra, Inc.
$941
Abbott Laboratories
$638
AstraZeneca Pharmaceuticals LP
$455
Amgen Inc.
$438
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$358
SANOFI-AVENTIS U.S. LLC
$334
Bayer Healthcare Pharmaceuticals Inc.
$328
Novartis Pharmaceuticals Corporation
$327
Boston Scientific Corporation
$325
Esperion Therapeutics, Inc.
$302
Philips North America LLC
$243
Merck Sharp & Dohme LLC
$229
Boehringer Ingelheim Pharmaceuticals, Inc.
$211
Amarin Pharma Inc.
$198
ABIOMED
$194
PFIZER INC.
$192
BIOTRONIK INC.
$189
Janssen Pharmaceuticals, Inc
$173
CVRx, Inc.
$128
Medtronic USA, Inc.
$125
Novo Nordisk Inc
$108
CARDIVA MEDICAL, INC.
$92
E.R. Squibb & Sons, L.L.C.
$87
W. L. Gore & Associates, Inc.
$85
Bayer HealthCare Pharmaceuticals Inc.
$74
United Therapeutics Corporation
$69
Philips Electronics North America Corporation
$66
Kiniksa Pharmaceuticals International, plc
$63
Cardiovascular Systems Inc.
$59
Merck Sharp & Dohme Corporation
$54
Regeneron Healthcare Solutions, Inc.
$45
Edwards Lifesciences Corporation
$39
Astellas Pharma US Inc
$36
Lexicon Pharmaceuticals, Inc.
$31
HEARTFLOW, INC.
$29
Actelion Pharmaceuticals US, Inc.
$28
Silk Road Medical, Inc.
$27
BOSTON SCIENTIFIC CORPORATION
$16
Innovation Technologies Inc
$15
Kowa Pharmaceuticals America, Inc.
$15
ARALEZ PHARMACEUTICALS US INC.
$15
CashFlow Solutions, LLC
$11
Top 3 companies account for 57.4% of total payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · (CM9) Amb Mon & Diag Und · ACCENT · ASSURITY · AVEIR · Arcalyst · Assurity Pacemaker · BELSOMRA · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CHANTIX · CONFIRM RX · Confirm Rx · Connectivity and Remote care · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · ELIQUIS · ENROUTE Transcarotid Stent · ENTRESTO · EVKEEZA · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRct · GALLANT · GENERAL THERAPIES · Impella · Indigo · Irrisept · JANUVIA · JARDIANCE · KYPHON Balloon Kyphoplasty · Kerendia · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LYMPHA PRESS OPTIMAL PLUS(US) BT · LifeVest · Livalo · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · NAVITOR · NEXLETOL · NEXLIZET · NONE · OPSUMIT · OPTOWIRE · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Penumbra System · Repatha · Reveal LINQ · Rhythmia Mapping System · Rybelsus · SAPIEN 3 Ultra RESILIA · STEGLATRO · TYVASO · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $65 per 100 Medicare services performed
Looking for a cardiovascular disease in Port Charlotte?
Compare cardiovascular diseases in the Port Charlotte area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
37
Per 100K population
19.0
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 19%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Patel performed 12,762 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $13,658 from 43 companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other cardiovascular diseases in Port Charlotte?
Dr. Patel's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →